The Connected Insights product line harnesses extensive knowledge sources via powerful API-integrations for streamlined variant interpretation, including prioritization of relevant clinical trials, drug labels, and guidelines for clinical research. Control over your standardized workflows enables flexibility, and automation speeds your time to relevant insights with procedural consistency. Connected Insights helps you address the interpretation bottleneck and move our understanding of disease forward.
Harness the power of API-integrated knowledge sources into a single solution to bring insights to diverse applications. Automate your interpretation workflows with customizable presets.
Remove unnecessary touchpoints and manual data movement for your NGS workflow, from sequencing through draft report. Seamless and secure, upstream and downstream, directly integrate with the latest DRAGEN Secondary Analysis.
Keep pace with comprehensive test options that enable diverse variant and biomarker analyses. Expand assay applications and scale volume without increasing headcount and interpretation resources.
Generate insights using 45+ knowledge sources including JAX-CKB™, CIViC and OncoKB (coming soon) via API-calling.
Grow and manage your lab's private curated knowledge.
From data upload to report generation – configure your settings and automate for a streamlined experience with minimum touchpoints.
Evolve with confidence across assays and applications — from panels to genomes and transcriptomes, from tissue to liquid biopsy and heme.
Configure regional content, preferences and language to meet regional needs.
Employ security-first infrastructure and conform to privacy and compliance software requirements and regulations.
Identify key DNA variant types (SVs, MNVs, exon-level CNVs, indels, fusions, tandem repeats, LOH) relevant in multiple disease types and across a variety of NGS assays.
Analyze variants from RNA or transcriptomics (fusions, splice variants, and soon expression levels) to gain a deeper and more comprehensive understanding of malignancies.
Uncover more insights by interpreting genome- wide pan-cancer biomarker signatures (TMB, MSI, HRD) with increasing relevance to precision medicine.
Prepare libraries for somatic oncology panels or other compatible applications.
Sequence libraries using any Illumina or other sequencing platform.
Call variants with DRAGEN or other secondary analysis tools to generate VCF (Variant Call Format) output.
Input VCF files to Connected Insights to enable generation of insights and case reporting.
To meet the most stringent security requirements, Illumina Connected Insights platform is built with security and compliance at its core. Read the security brief for more details.
Configure once with a fine level of granularity to match your lab’s standard operating procedure (SOP). Accelerate your workflow by leveraging automation configured according to your SOP.
Grow your lab’s private knowledge base with every case and instantly interpret cases against your historical experience. Your curated knowledge is private, secure, and always at your fingertips.
Customize based on lab name, lab branding, sections, fields, and more. Easily edit reports without data reingestion. Export reports in any language.
Save time with automated data upload after one-time configuration. Enjoy workflows with no touchpoints from Illumina sequencers.
Quickly view key findings, coverage, and QC summary in a consolidated format. Intuitively access deeper evidence sources with a streamlined user interface design.
Accelerate turnaround time by automating your exact SOP from variant QC and prioritization to interpretation and reporting by configuring disease, guideline, and lab-specific settings.
Deepen your insights with cutting-edge visualizations –explore genome view, DNA and RNA coverage plots, variant allele frequency (VAF) distribution plots, and more.
Watch this video to understand how the Connected Insights product line can connect various knowledge sources to streamline data interpretation operations for critical insights.
Key opinion leaders discuss the ongoing challenges and future potential of NGS in clinical oncology.
Comprehensive genomic profiling (CGP) uses a single assay to assess hundreds of genes including relevant cancer biomarkers, as established in guidelines and clinical trials, for therapy guidance.
Focus on sequencing coding regions, which frequently contain mutations that affect tumor progression, for a cost-effective approach.
Laboratory information management system that helps genomics labs track samples and manage workflows for an optimized and efficient lab.
The Illumina DRAGEN Bio-IT platform provides accurate, comprehensive, and efficient analysis of next-generation sequencing data.